Related Experiment Videos
Lysosomal enzyme replacement using alpha 2-macroglobulin as a transport vehicle
1Department of Biological Science and Technology, Faculty of Engineering, University of Tokushima.
Journal of Biochemistry
|May 1, 1994
Summary
Alpha 2-macroglobulin can effectively deliver lysosomal enzymes to cells for enzyme replacement therapy. This approach successfully treated glycogen and globotriaosylceramide accumulation in lysosomal storage diseases.
Area of Science:
- Biochemistry
- Cell Biology
- Genetics
Background:
- Enzyme replacement therapy (ERT) is crucial for treating lysosomal storage diseases.
- Efficient delivery of exogenous enzymes to target cells remains a significant challenge in ERT.
Purpose of the Study:
- To investigate alpha 2-macroglobulin as a potential transport vehicle for lysosomal enzymes.
- To assess the efficacy of alpha 2-macroglobulin-enzyme conjugates in treating lysosomal storage diseases.
Main Methods:
- Coupling of acid alpha-glucosidase and alpha-galactosidase A to alpha 2-macroglobulin using heterobifunctional cross-linking reagents.
- Evaluating the internalization, lysosomal transport, and therapeutic activity of the conjugates in deficient fibroblast models.
- Investigating the endocytosis pathway using alpha 2-macroglobulin-trypsin complex.
Main Results:
- Alpha 2-macroglobulin conjugates of both enzymes were successfully internalized and transported into lysosomes.
- The enzyme activity remained stable post-internalization, leading to degradation of accumulated substrates (glycogen and globotriaosylceramide).
- Endocytosis was mediated by the alpha 2-macroglobulin receptor system.
Conclusions:
- Alpha 2-macroglobulin serves as an effective transport vehicle for lysosomal enzymes.
- This strategy holds promise for improving enzyme replacement therapy in lysosomal storage diseases.